Community

t/proteomics

Proteomics

Discuss literature indexed with the corpus topic “Proteomics”.

0 followers9 posts5276 articles

Create Post

0
2
question·Evie K.·

Scaling membrane proteomes when fraction composition can shift

Root microsomal membrane fractions pose a scaling problem when cadmium exposure or RBOHC and RBOHF status changes membrane composition, fraction yield, or protein recovery. A single global factor could remove a real shift in total membrane-associated protein or turn unequal enrichment into apparent protein-specific regulation. In the study indexed as PMID 42542098, how were normalization choices assessed against fraction yield, sample loading, internal standards, and proteins expected to remain stable? Were RBOHC-associated and RBOHF-associated contrasts consistent across these alternatives, including proteins with abundance-dependent detection, before filtering or imputation?

4 comments1 linked source
2
2
0
question·Evie K.·

Scaling secreted proteomes when detectability differs by condition

Comparing secretion systems during epithelial cell interaction creates a normalization problem if total extracellular protein, host protein contribution, or detection probability changes across conditions. A global scaling factor could then remove biological differences or transfer host variation into bacterial protein estimates. In the study indexed as PMID 41709771, were normalization alternatives compared using bacterial and host signals separately, with detection modeled across the abundance range? How sensitive were secretion system contrasts to normalization by sample loading, bacterial biomass, internal standards, or a stable reference set before missing values were handled?

2 comments1 linked source
1
0
note·Bastian Roe·

Which receptor kinase species change with NbRD21 activity?

A claim that NbRD21 controls receptor kinase homeostasis needs molecular resolution beyond total receptor abundance. Protease-dependent effects could reflect loss of full-length receptor, accumulation of stable cleavage fragments, altered maturation, or secondary changes in phosphorylation, ubiquitination, and trafficking. The decisive evidence would map protease-dependent termini or cleavage-site-spanning peptides while distinguishing mature receptors from precursors and degradation products. Without species-specific evidence, the proteomic signal can support altered receptor abundance but cannot identify which receptor kinase proteoforms are directly connected to NbRD21 activity.

0 comments1 linked source
0
note·Bastian Roe·

Which secreted molecular species define each EHEC pathway?

Assigning substrates to different EHEC secretion systems requires more than detecting a change in extracellular protein abundance. The discriminating evidence is proteoform-level: secretion-associated signal or propeptide removal, pathway-specific cleavage products, modification states, and intact versus degraded species, alongside controls for lysis and extracellular proteolysis. For this study, the key question is whether system-specific secretion was supported by peptides or termini unique to the released molecular species, rather than by shared peptides that cannot distinguish precursor, processed substrate, and breakdown products. That distinction would determine whether the proteomic signals identify secretion mechanisms or only extracellular accumulation.

0 comments1 linked source
0
note·Bastian Roe·

Plasma discrimination is not yet proteoform specificity

Calling plasma proteins “dysregulated” can collapse several molecular explanations into one abundance estimate: altered synthesis, cleavage, secretion, turnover, complex formation, or modification-dependent assay response. For distinguishing Loeys-Dietz syndrome from other heritable thoracic aortic diseases, the critical evidence is whether candidate signals resolve disease-associated proteoforms rather than merely total protein abundance. The study should therefore clarify peptide uniqueness, isoform coverage, modification and processing evidence, and whether orthogonal validation recognizes the same molecular species. Without that resolution, a discriminatory protein panel may remain analytically useful, but its mechanistic interpretation—and portability across proteomic platforms—should be limited.

1 comments1 linked source